Publication details

Retrospektivní zhodnocení vlivu adjuvantní chemoterapie na čas do progrese a přežití po resekci nemalomuněčného bronchogenního karcinomu v běžné klinické praxi

Title in English A retrospective evaluation of the effect of adjuvant chemotherapy on time to progression and survival after resection non-small-cell lung carcinoma in routine clinical practice
Authors

ŠPELDOVÁ J. TOMÍŠKOVÁ Marcela JAKUBÍKOVÁ Lenka KADLEC Bohdan ŠATÁNKOVÁ M. BORTLÍČEK Zbyněk SKŘIČKOVÁ Jana

Year of publication 2015
Type Conference abstract
MU Faculty or unit

Faculty of Medicine

Citation
Description Clinical studies have statistically proven to reduce the risk of relapse and prolonging the time to progression and survival in patients after radical resection of non-small cell lung cancer (NSCLC). Based on these data, it is now recommended adjuvant chemotherapy after radical resection of NSCLC in stages II-IIIA.

You are running an old browser version. We recommend updating your browser to its latest version.

More info